DihydrocapsiateCAS# 205687-03-2 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 205687-03-2 | SDF | Download SDF |
PubChem ID | 9873754 | Appearance | Powder |
Formula | C18H28O4 | M.Wt | 308.4 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (4-hydroxy-3-methoxyphenyl)methyl 8-methylnonanoate | ||
SMILES | CC(C)CCCCCCC(=O)OCC1=CC(=C(C=C1)O)OC | ||
Standard InChIKey | RBCYRZPENADQGZ-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C18H28O4/c1-14(2)8-6-4-5-7-9-18(20)22-13-15-10-11-16(19)17(12-15)21-3/h10-12,14,19H,4-9,13H2,1-3H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Dihydrocapsiate Dilution Calculator
Dihydrocapsiate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.2425 mL | 16.2127 mL | 32.4254 mL | 64.8508 mL | 81.0636 mL |
5 mM | 0.6485 mL | 3.2425 mL | 6.4851 mL | 12.9702 mL | 16.2127 mL |
10 mM | 0.3243 mL | 1.6213 mL | 3.2425 mL | 6.4851 mL | 8.1064 mL |
50 mM | 0.0649 mL | 0.3243 mL | 0.6485 mL | 1.297 mL | 1.6213 mL |
100 mM | 0.0324 mL | 0.1621 mL | 0.3243 mL | 0.6485 mL | 0.8106 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Isovaltrate
Catalog No.:BCN0268
CAS No.:31078-10-1
- Eleutheroside B1
Catalog No.:BCN0267
CAS No.:16845-16-2
- (-)-Conduritol F
Catalog No.:BCN0266
CAS No.:6090-98-8
- Cynandione A
Catalog No.:BCN0265
CAS No.:168706-29-4
- Wilfoside C 1N
Catalog No.:BCN0264
CAS No.:96829-53-7
- Bungeiside B
Catalog No.:BCN0263
CAS No.:149561-88-6
- Wilfoside K 1N
Catalog No.:BCN0262
CAS No.:100802-91-3
- (Z)-5-(Heptadec-10-en-1-yl)resorcinol
Catalog No.:BCN0261
CAS No.:52483-21-3
- Belamcandol B
Catalog No.:BCN0260
CAS No.:137786-94-8
- Deoxy euphorbia factor L1
Catalog No.:BCN0259
CAS No.:247099-01-0
- Euphorbia factor L22
Catalog No.:BCN0258
CAS No.:1613700-09-6
- Planispine A
Catalog No.:BCN0257
CAS No.:1202761-42-9
- Nordihydrocapsiate
Catalog No.:BCN0270
CAS No.:220012-53-3
- Colnelenic acid
Catalog No.:BCN0271
CAS No.:52591-16-9
- Capsiate
Catalog No.:BCN0272
CAS No.:205687-01-0
- Vaticanol B
Catalog No.:BCN0273
CAS No.:287101-83-1
- Soyasaponin III
Catalog No.:BCN0287
CAS No.:55304-02-4
- Soyasaponin A3
Catalog No.:BCN0288
CAS No.:114077-04-2
- Soyasaponin A1
Catalog No.:BCN0289
CAS No.:78693-94-4
- Vatalbinoside A
Catalog No.:BCN0274
CAS No.:
- Vatalbinoside C
Catalog No.:BCN0275
CAS No.:
- Vatalbinoside G
Catalog No.:BCN0276
CAS No.:
- Vatalbinoside H
Catalog No.:BCN0277
CAS No.:
- Vatalbinoside J
Catalog No.:BCN0278
CAS No.:
Effects of Capsinoids on Daily Physical Activity, Body Composition and Cold Hypersensitivity in Middle-Aged and Older Adults: A Randomized Study.[Pubmed:31947529]
Nutrients. 2020 Jan 14;12(1). pii: nu12010212.
Sedentary/inactive lifestyle leads middle-aged and older adults to metabolic syndrome and frailty. Capsinoids from nonpungent chili pepper cultivar have been reported to reduce body fat mass, promote metabolism, and improve unidentified complaints of chills. Additionally, they have an anti-inflammation effect; therefore, we hypothesized that continuous oral ingestion of capsinoids alleviates age-related inflammation in the brain and improves the physical activity (PA) in middle-aged and older adults. In our double-blind human study, 69 participants (17 male, 52 female; mean age: 74.1 +/- 7.7 years; range: 52-87 years) were administered either 9 mg of capsinoids which were extracted from pepper fruit variety CH-19 Sweet (Capsicum anuum L.) (CP group), or a placebo (PL group) daily over a 3 month period. In an animal study, PA and inflammation-related mRNA expression in the brain were examined in 5-week (young) and 53-week (old) aged mice fed a diet with or without 0.3% Dihydrocapsiate, a type of capsinoids, for 12 weeks. In a human study, capsinoids intake did not increase the amount of light-to-moderate PA less than 6.0 metabolic equivalents (METs) (CP: 103.0 +/- 28.2 at baseline to 108.2 +/- 28.3 at 12 weeks; PL: 104.6 +/- 19.8 at baseline to 115.2 +/- 23.6 at 12 weeks, METs x hour/week); however, in participants exhibiting an inactive lifestyle, it showed significant increase (CP: 84.5 +/- 17.2 at baseline to 99.2 +/- 24.9 at 12 weeks; PL: 99.7 +/- 23.3 at baseline to 103.8 +/- 21.9 at 12 weeks). The energy expenditure in physical activity also improved in the inactive CP group (CP: 481.2 +/- 96.3 at baseline to 562.5 +/- 145.5 at 12 weeks; PL: 536.8 +/- 112.2 at baseline to 598.6 +/- 127.6 at 12 weeks; kcal/day). In all participants, CP showed reduced waist circumference, percent body fat, and visceral fat volume; in addition, chills were eased in subjects aged 80 years and older. The older mice fed capsinoids showed increased locomotion activity, decreased inflammation, and oxidative stress in the brain. The results suggest that the continuous oral ingestion of capsinoids gains PA through anti-inflammation effect in the brain as well as reduces fat accumulation and chills in inactive and older humans.
Assessment of Capsaicinoid and Capsinoid Accumulation Patterns during Fruit Development in Three Chili Pepper Genotypes (Capsicum spp.) Carrying Pun1 and pAMT Alleles Related to Pungency.[Pubmed:31613626]
J Agric Food Chem. 2019 Nov 6;67(44):12219-12227.
Quantification, using an accurate analytical approach, of capsinoids and capsaicinoids was performed on three chili pepper (Capsicum spp.) genotypes: "Chiltepin", "Tampiqueno 74", and "Bhut Jolokia" at various stages of fruit development. The accumulation of capsinoids, in all these peppers started between 10 to 20 days post-anthesis (dpa), increased and reached the highest capsinoid amount at 40 dpa, and then decreased until 60 dpa. Conversely, capsaicinoids could already be determined at 10 dpa in "Bhut Jolokia" and their accumulation pattern was different from that of the capsinoids in this genotype. The capsiate/Dihydrocapsiate ratio presented a higher variation between genotypes and developmental stages than the capsaicin/dihydrocapsaicin ratio. Capsinoid ratios (4-24%) and Pun1/pAMT genotyping were determined. These results provide information on the progress of the accumulation of capsinoids in the aforementioned pungent and superhot cultivars and could support future breeding studies toward the understanding of the factors affecting their accumulation.